Hims & Hers Health (HIMS) News Today $26.20 -0.16 (-0.61%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Hims & Hers Health: Sell Rating Due to Compounding Exemption Risks and Uncertain GLP-1 ContributionsDecember 21 at 4:30 AM | markets.businessinsider.comGeode Capital Management LLC Increases Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS)Geode Capital Management LLC boosted its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 12.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,289,549 shares of the company's stock after aDecember 21 at 4:09 AM | marketbeat.comBarclays PLC Has $5.68 Million Stake in Hims & Hers Health, Inc. (NYSE:HIMS)Barclays PLC grew its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 9.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 308,363 shares of the company's stockDecember 21 at 3:56 AM | marketbeat.comHims & Hers falls -12.0%December 20 at 8:57 AM | markets.businessinsider.comHims & Hers Stock: Growth, Noise, and Where to Focus NowDecember 20 at 6:00 AM | fool.comFranklin Resources Inc. Sells 222,660 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)Franklin Resources Inc. trimmed its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 15.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,177,195 shares of the company's stock after selling 222,6December 20 at 5:08 AM | marketbeat.comHims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It LastedDecember 19 at 4:42 PM | seekingalpha.comHims & Hers Health (NYSE:HIMS) Shares Gap Down - Should You Sell?Hims & Hers Health (NYSE:HIMS) Shares Gap Down - Here's WhyDecember 19 at 11:03 AM | marketbeat.comHims & Hers shares tumble as FDA resolves obesity drug shortageDecember 19 at 10:30 AM | au.investing.comHims & Hers Stock Skyrockets 200%, Then Is Crashing--What's Next for This Telehealth Powerhouse?December 19 at 10:30 AM | finance.yahoo.comHims & Hers Health falls as FDA issues unfavorable compounded GLP-1 decisionDecember 19 at 10:30 AM | msn.comAndrew Dudum Sells 78,127 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockDecember 19 at 4:21 AM | americanbankingnews.comFmr LLC Lowers Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)Fmr LLC reduced its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 99.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,131 shares of the company's stock after selling 3,808December 19 at 3:07 AM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Receives $21.43 Consensus Price Target from BrokeragesDecember 19 at 1:29 AM | americanbankingnews.comIrene Becklund Sells 472 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockDecember 18 at 6:55 AM | insidertrades.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 472 Shares of StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Irene Becklund sold 472 shares of the firm's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $29.58, for a total value of $13,961.76. Following the sale, the insider now owns 17,331 shares in the company, valued at $512,650.98. This trade represents a 2.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.December 17, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) CEO Sells $2,314,121.74 in StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CEO Andrew Dudum sold 78,127 shares of the firm's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $29.62, for a total transaction of $2,314,121.74. Following the completion of the transaction, the chief executive officer now owns 109,956 shares in the company, valued at $3,256,896.72. The trade was a 41.54 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.December 17, 2024 | marketbeat.comMorgan Stanley Initiates Coverage of Hims & Hers Health (HIMS) with Overweight RecommendationDecember 17, 2024 | msn.comHims & Hers Health, Inc. (NYSE:HIMS) Sees Large Growth in Short InterestHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) saw a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 42,620,000 shares, a growth of 7.8% from the November 15th total of 39,520,000 shares. Based on an average trading volume of 15,600,000 shares, the days-to-cover ratio is currently 2.7 days. Currently, 24.0% of the shares of the company are sold short.December 17, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Gap Up - Time to Buy?Hims & Hers Health (NYSE:HIMS) Shares Gap Up - Still a Buy?December 17, 2024 | marketbeat.comTesla, crypto miners, Hims & Hers Health: Trending TickersDecember 17, 2024 | finance.yahoo.comMorgan Stanley Initiates Bullish Coverage on Hims & Hers Health with 37% UpsideDecember 17, 2024 | finance.yahoo.comMorgan Stanley Initiates Coverage on Hims & Hers Health (NYSE:HIMS)Morgan Stanley initiated coverage on shares of Hims & Hers Health in a report on Tuesday. They issued an "overweight" rating and a $42.00 price target for the company.December 17, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Shares Purchased by State Street CorpState Street Corp increased its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 4.7% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 4,626,543 shares of the company's stock after acquiring an additional 206,078 shaDecember 17, 2024 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)December 16, 2024 | markets.businessinsider.comHims & Hers Health, Inc. (NYSE:HIMS) Given Average Recommendation of "Hold" by AnalystsHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) has been given an average rating of "Hold" by the sixteen ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendaDecember 16, 2024 | marketbeat.comTruist Financial Gives a Hold Rating to Hims & Hers Health (HIMS)December 14, 2024 | markets.businessinsider.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 7,259 Shares of StockDecember 13, 2024 | insidertrades.comThe Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About WeightDecember 12, 2024 | finance.yahoo.comChallenging Outlook for Hims & Hers Health Amid DTC Model Disruption and Profit Margin ConcernsDecember 12, 2024 | markets.businessinsider.comHims & Hers: Look At What Matters MostDecember 12, 2024 | seekingalpha.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 28,276 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 9.9% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 258,661 shares of tDecember 12, 2024 | marketbeat.comWall Street Sounds Alarm On Hims & Hers Amid Ro-Eli Lilly Zepbound Tie-Up: Retail Shrugs It OffDecember 11, 2024 | msn.com4 Stocks That Crushed Analyst Estimates by More Than DoubleHims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential.December 11, 2024 | marketbeat.comNeo Ivy Capital Management Makes New $1.25 Million Investment in Hims & Hers Health, Inc. (NYSE:HIMS)Neo Ivy Capital Management purchased a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 67,936 shares of the company's stock, valuedDecember 11, 2024 | marketbeat.comWellington Management Group LLP Acquires 883,230 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)Wellington Management Group LLP boosted its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 34.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,444,414 shares of the company's stock after purchasDecember 11, 2024 | marketbeat.comY Intercept Hong Kong Ltd Increases Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)Y Intercept Hong Kong Ltd increased its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 312.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 134,018 shares of the company'sDecember 10, 2024 | marketbeat.comMain Management ETF Advisors LLC Takes Position in Hims & Hers Health, Inc. (NYSE:HIMS)Main Management ETF Advisors LLC acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 36,472 shares of the compaDecember 8, 2024 | marketbeat.comHims & Hers Health: Buy Rating Backed by Promising Growth in GLP-1 Market and Strong Telehealth PositioningDecember 7, 2024 | markets.businessinsider.comQuadrature Capital Ltd Lowers Position in Hims & Hers Health, Inc. (NYSE:HIMS)Quadrature Capital Ltd trimmed its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 69.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 156,299 shares of the company's stock after selling 35December 6, 2024 | marketbeat.comBank of Montreal Can Sells 155,053 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)Bank of Montreal Can trimmed its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 59.3% in the third quarter, according to its most recent filing with the SEC. The firm owned 106,349 shares of the company's stock after selling 155,053 shares during the period. Bank of MonDecember 6, 2024 | marketbeat.comHims & Hers: The Show Must Go OnDecember 5, 2024 | seekingalpha.com2 Telehealth Stocks That Could Gain from Trump’s New FDA PickDiscover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate.December 5, 2024 | marketbeat.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 2,054 Shares of StockDecember 4, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 15.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,667,422 shares of thDecember 4, 2024 | marketbeat.comHims & Hers Named to Inc.’s 2024 Best in Business List in Health Products CategoryDecember 3, 2024 | finance.yahoo.comHims & Hers Named to Inc.'s 2024 Best in Business List in Health Products CategoryDecember 3, 2024 | businesswire.comHims & Hers price target raised to $38 from $28 at CanaccordDecember 3, 2024 | markets.businessinsider.comHims & Hers Health, Inc. (NYSE:HIMS) Position Boosted by Verition Fund Management LLCVerition Fund Management LLC increased its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 15.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 645,731 shares of the company's stock after purchasing an additional 84,31December 1, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Has $9.18 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)Healthcare of Ontario Pension Plan Trust Fund reduced its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 5.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 498,500 shares of the company's stock afterNovember 30, 2024 | marketbeat.com Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with … Find out details on these three critical Nvidia partners immediately. HIMS Media Mentions By Week HIMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.480.60▲Average Medical News Sentiment HIMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼2914▲HIMS Articles Average Week Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NTRA News Today FMS News Today GH News Today OPCH News Today SHC News Today VCYT News Today BTSG News Today LFST News Today SGRY News Today CON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.